- Home
- GRNT vs PAHC Comparison
GRNT vs PAHC Comparison
Compare GRNT & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRNT
- PAHC
- Stock Information
- Founded
- GRNT 2013
- PAHC 1946
- Country
- GRNT United States
- PAHC United States
- Employees
- GRNT N/A
- PAHC N/A
- Industry
- GRNT Blank Checks
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- GRNT Finance
- PAHC Health Care
- Exchange
- GRNT Nasdaq
- PAHC Nasdaq
- Market Cap
- GRNT 752.6M
- PAHC 968.3M
- IPO Year
- GRNT N/A
- PAHC 2014
- Fundamental
- Price
- GRNT $6.38
- PAHC $25.61
- Analyst Decision
- GRNT Buy
- PAHC Sell
- Analyst Count
- GRNT 2
- PAHC 4
- Target Price
- GRNT $7.50
- PAHC $21.25
- AVG Volume (30 Days)
- GRNT 934.9K
- PAHC 235.7K
- Earning Date
- GRNT 08-07-2025
- PAHC 05-07-2025
- Dividend Yield
- GRNT 6.90%
- PAHC 1.89%
- EPS Growth
- GRNT N/A
- PAHC 140.17
- EPS
- GRNT 0.09
- PAHC 0.78
- Revenue
- GRNT $390,665,000.00
- PAHC $1,190,682,000.00
- Revenue This Year
- GRNT $30.32
- PAHC $28.33
- Revenue Next Year
- GRNT $7.79
- PAHC $13.78
- P/E Ratio
- GRNT $70.80
- PAHC $32.60
- Revenue Growth
- GRNT 6.26
- PAHC 19.12
- 52 Week Low
- GRNT $4.52
- PAHC $16.16
- 52 Week High
- GRNT $7.10
- PAHC $26.55
- Technical
- Relative Strength Index (RSI)
- GRNT 76.17
- PAHC 67.45
- Support Level
- GRNT $6.29
- PAHC $24.59
- Resistance Level
- GRNT $6.72
- PAHC $25.37
- Average True Range (ATR)
- GRNT 0.21
- PAHC 0.74
- MACD
- GRNT 0.05
- PAHC -0.01
- Stochastic Oscillator
- GRNT 93.81
- PAHC 97.23
About GRNT Granite Ridge Resources Inc.
Granite Ridge Resources Inc is a scaled, non-operated oil and gas exploration and production company. It invests in a diversified portfolio of production and top-tier acreage across the Permian and other prolific U.S. basins in partnership with operators. It generates maximum revenue from Oil.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.